Correction (DOI:10.1016/j.ahj.2007.02.010);Absence of bilateral vision loss from amiodarone: A randomized trial

American Heart Journal

Volumn 153, Issue 5, 2007, Pages 837-842

  Mindel, Joel S ^a   Anderson, Jill ^b,c   Johnson, George ^b   Hellkamp, Anne ^c   Poole, Jeanne E ^d   Mark, Daniel B ^d   Lee, Kerry L ^c   Bardy, Gust H ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; PLACEBO;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BODY WEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE DURATION; DRUG EFFECT; DRUG LABELING; FOLLOW UP; GROUPS BY AGE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; OPTIC NEURITIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL TIME; TREATMENT DURATION;

EID: 34247163526     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.05.004     Document Type: Erratum

References (25)

1. Hattenbauer M.G., Leavitt J.A., Hodge D.O., et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123 (1997) 103-107
2. Feiner L.A., Younge B.R., Kazmier F.J., et al. Optic neuropathy and amiodarone therapy. Mayo Clin Proc 62 (1987) 702-717
3. Johnson L.N., Krohel G.B., and Thomas E.R. The clinical spectrum of amiodarone induced optic neuropathy. J Natl Med Assoc 96 (2004) 1477-1491
4. Stelfox H.T., Ahmed S.B., Fiskio J., et al. Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice. Clin Pharmacol Ther 75 (2004) 110-122
5. Jacobson D.M., Vierkant R.A., and Belongia E.A. Nonarteritic anterior ischemic optic neuropathy: a case-control study of potential risk factors. Arch Ophthalmol 115 (1997) 1403-1407
6. Hayreh S.S., Joos K.M., Podhajsky P.A., et al. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118 (1994) 766-780
7. Ingram D.V., Jaggarao N.S., and Chamberlain D.A. Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol 66 (1982) 676-679
8. Ghosh M., and McCulloch C. Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol 19 (1984) 178-186
9. Bardy G.H., Lee K.L., Mark D.P., et al., for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
10. Harris M.I., Flegal K.M., Cowie C.C., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. Diabetes Care 21 (1998) 518-524
11. Fields L.E., Birt V.L., Cutler J.A., et al. The burden of adult hypertension in the United States. A rising tide. Hypertension 44 (2004) 398-404
12. Grant S.W., and Schuman J. Chapter 1. Introductory outline of toxic effects on the eyes and vision. Toxicology of the eye. 4th ed. (1993), Charles C. Thomas Publisher, Springfield (IL) 30
13. Nagra P.K., Foroozan R., Savino P.J., et al. Amiodarone-induced optic neuropathy. Br J Ophthalmol 87 (2003) 420-422
14. Sreih A.G., Schoenfeld M.H., and Marieb M.A. Optic neuropathy following amiodarone therapy. PACE 22 (1999) 1108-1110
15. Palimar P., and Cota N. Bilateral anterior ischaemic optic neuropathy following amiodarone. Eye 12 (1998) 894-895
16. Seemongal-Dass R.R., and Spencer S.R. Bilateral optic neuropathy linked with amiodarone. Eye 12 (1998) 474-477
17. GittingerJr J.W., and Asdourian G.K. Papillopathy caused by amiodarone. Arch Ophthalmol 105 (1987) 349-351
18. Eryilmaz T., Atilla H., Batioglu F., et al. Amiodarone-related optic neuropathy. Jpn J Ophthalmol 44 (2000) 565-568
19. Nazarian S.M., and Jay W.M. Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuroophthalmol 8 (1988) 25-28
20. Castella D.D., Teitelbaum B.A., and Tresley D.J. Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy. Optometry 73 (2002) 113-121
21. Speicher M.A., Goldman M.H., and Chrousos G.A. Amiodarone optic neuropathy without disc edema. J Neuroophthalmol 20 (2000) 171-172
22. Purvin V., Kawasaki A., and Borraut F.X. Optic neuropathy in patients using amiodarone. Arch Ophthalmol 124 (2006) 696-701
23. Totah R.A., and Rettie A.E. Cytochrome P450 2C8: Substrates inhibitors, pharmacogenetics and relevance. Clin Pharmacolb Ther 77 (2005) 341-352
24. Bailey D.G., and Dresser G.K. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 4 (2004) 281-297
25. Lesko L.J. Pharmacokinetic drug interactions with amiodarone. Clin Pharmacokinet 17 (1989) 130-140